Search results for "crossover"
showing 10 items of 658 documents
Distance-based relevance feedback using a hybrid interactive genetic algorithm for image retrieval
2011
Content-based image retrieval (CBIR) systems aim to provide a means to find pictures in large repositories without using any other information except the own content of the images, which is usually represented as a feature vector extracted from low-level descriptors. This paper describes a CBIR algorithm which combines relevance feedback, evolutionary computation concepts and distance-based learning in an attempt to reduce the existing gap between the high level semantic content of the images and the information provided by their low-level descriptors. In particular, a framework which is independent from the particular features used is presented. The effect of different crossover strategies…
Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy
2007
In this randomized, double-blind, crossover clinical trial, adult patients treated two migraine attacks: one with almotriptan 12.5 mg and the other with ergotamine 2 mg plus caffeine 200 mg. Treatment with almotriptan was associated with a significantly greater proportion of patients achieving 2-h pain free (20.9% vs. 13.7%; P < 0.05) and 2-h pain relief (57.7% vs. 44.5%; P < 0.01) compared with ergotamine plus caffeine therapy; significant differences were not seen at 1 h. Rates for sustained pain free and sustained pain free plus no adverse events (AEs) also were significantly greater after almotriptan treatment than after the use of ergotamine plus caffeine (P < 0.05). Almotriptan was as…
Effects of Caffeine as an Adjuvant to Morphine in Advanced Cancer Patients
2001
Psychomotor abnormalities are one of the complications of opioid therapy in advanced cancer patients. Caffeine has potential properties to counteract the central effects of morphine. Twelve patients receiving stable doses of slow release morphine with adequate pain relief were scheduled for this double-blind placebo-controlled crossover trial. The treatment consisted of an intravenous dose of 1/6 of the daily morphine dose, using an intravenous/oral conversion ratio of 1:3. The dose calculated was administered in 5 minutes. Patients were randomly divided to received in a double-blind manner an infusion of 200 mg of caffeine or saline solution intravenously over one hour. A crossover took pl…
Coordination chemistry on surfaces through vapor phase processing: smart molecular/graphene heterostructures based on spin-crossover complexes and 2D…
2023
Los compuestos de coordinación están últimamente focalizando la atención de los investigadores en el campo de la nanociencia. Particular interés están generando aquellos compuestos con propiedades magnéticas de cara a su integración a la nanoescala en ramas como la electrónica y/o la espintrónica moleculares. Sin embargo, para su uso real en dispositivos destinados a estas aplicaciones, su procesabilidad es un requisito indispensable. En el marco de esta necesidad, la presente tesis doctoral se ha destinado al estudio del procesado sobre superficies mediante técnicas de fase gas de dos tipos distintos de compuestos de coordinación. Por tanto, el trabajo se ha dividido en dos partes. La prim…
Field-induced slow relaxation of magnetization in a mononuclear Co(II) complex of 2,6-bis(pyrazol-1-yl)pyridine functionalized with a carboxylic acid
2018
Abstract Combining Co(II) with the 2,6-bis-(pyrazol1-yl)pyridine ligand functionalized with a carboxylic acid group (bppCOOH) results in the compound [CoII(bppCOOH)2](ClO4)2·2Me2CO, which shows a field-induced slow relaxation of magnetization as a result of the magnetic anisotropy of the distorted octahedral coordination of high-spin Co(II). Co(II)/Fe(II) solid solutions of bppCOOH have been prepared to study the influence of Co(II) on the spin crossover properties of Fe(II). Magnetic characterization of [Fe0.92Co0.08(bppCOOH)2](ClO4)2 indicates that the Cobalt dopant leads to a reduction of T1/2 and a loss of cooperativity of the spin transition.
Thermal- and light-induced spin crossover in novel 2D Fe(II) metalorganic frameworks {Fe(4-PhPy)(2)[M(II)(CN)(x)](y)}.sH(2)O: spectroscopic, structur…
2009
Five novel two-dimensional coordination polymers {Fe(4PhPy)(2)[M(II)(CN)(4)]}.sH(2)O (4PhyPy = 4-phenylpyridine; 1: M(II) = Pd, s = 0; 2: M(II) = Ni, s = 0; 3: M(II) = Pt, s = 1) and {Fe(4PhPy)(2)[M(I)(CN)(2)](2)}.sH(2)O (4: M(I) = Ag, s = 1; 5: M(I) = Au, s = 0.5) exhibiting spin-crossover properties have been synthesized. They were characterized at various temperatures using X-ray absorption spectroscopy (XAS), powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC), and magnetic susceptibility measurements. The occurrence of a cooperative thermal spin transition detected by the magnetic method is located at critical temperatures T(c)( downward arrow)/T(c)( upward arrow) …
Fe(II) spin crossover complexes of a derivative of 2,6-bis(pyrazol-1-yl)pyridine (1-bpp) functionalized with a carboxylic acid in the 3-pyridyl posit…
2019
Abstract The preparation of a new bis(pyrazol-1-yl)pyridine (1-bpp) derivative functionalized with a carboxylic acid in the 3-pyridyl position, bpp3-COOH ligand is reported together with the structure and spin-crossover (SCO) properties of [FeII(bpp3-COOH)2](ClO4)2·0.5EtOH·0.5H2O (1). Magnetic properties of 1 indicate that LS is favored. Desolvation leads to a gradual and incomplete SCO. Solvated and desolvated compounds show LIESST effect.
Heteroleptic Iron(II) Spin-Crossover Complexes Based on a 2,6-Bis(pyrazol-1-yl)pyridine-type Ligand Functionalized with a Carboxylic Acid
2019
Two new heteroleptic complexes [Fe- (1bppCOOH)(3bpp-bph)](ClO4)2·solv (1·solv, solv = various solvents; 1bppCOOH = 2,6-bis(1H-pyrazol-1-yl)- isonicotinic acid; 3bpp-bph = 2,6-bis(5-([1,1′-biphenyl]-4- yl)-1H-pyrazol-3-yl)pyridine) and [Fe(1bppCOOH)- (1bppCOOEt)](ClO4)2 ·0.5Me2CO (2·0.5Me2CO, 1bppCOOEt = ethyl 2,6-bis(1H-pyrazol-1-yl)isonicotinate) were designed and prepared. The heteroleptic compound 1· solv was obtained by the combination of stoichiometric amounts of Fe(ClO4)2, 1bppCOOH, and 3bpp-bph, and it was designed to fine-tune the spin crossover (SCO) properties with respect to the previously reported homoleptic compound [Fe(1bppCOOH)2](ClO4)2. Indeed, the introduction of a new subs…
Spin-crossover compounds based on iron(II) complexes of 2,6-bis(pyrazol-1-yl)pyridine (bpp) functionalized with carboxylic acid and ethyl carboxylic …
2018
International audience; Four new salts of the iron(II) complex of the 2,6-bis(pyrazol-1-yl)pyridine ligand functionalized with a carboxylic acid group (bppCOOH) of formulas [Fe(bppCOOH)2](BF4)2 (1(BF4)2), [Fe(bppCOOH)2](CF3SO3)2·yMe2CO (1(CF3SO3)2·yMe2CO), [Fe(bppCOOH)2](AsF6)2·yMe2CO (1(AsF6)2·yMe2CO) and [Fe(bppCOOH)2](SbF6)2·yMe2CO (1(SbF6)2·yMe2CO) have been prepared and characterized together with a more complete structural and photomagnetic characterization of the previously reported [Fe(bppCOOH)2](ClO4)2 (1(ClO4)2). Furthermore, the iron(II) complex of the ethyl ester derivative of bppCOOH (bppCOOEt) has been prepared and characterized (compound [Fe(bppCOOEt)2](ClO4)2·yMe2CO, 2(ClO4)…
Iron(II) complex of 2-(1H-pyrazol-1-yl)pyridine-4-carboxylic acid (ppCOOH) suitable for surface deposition
2018
The synthesis, structural and magnetic characterization of the tris iron(II) complex of 2-(1H-pyrazol-1-yl)pyridine-4-carboxylic acid (ppCOOH) ligand are reported in [Fe(ppCOOH)3](ClO4)2·0.5H2O·2EtOH. Single crystal structure and magnetic characterization of the bulk compound show that the low-spin state is dominant from 2 to 400 K. ESI-MS and UV–Vis spectroscopy experiments indicate that acetonitrile solutions of this complex are stable with time. ESI-MS confirms the presence of the tris complex in solution. This complex can be deposited onto SiO2 surfaces due to the presence of carboxylic acid groups by immersing the substrates into acetonitrile solutions of the complex. XPS spectra of th…